Name,Empirical formula,CAS,SMILES,Canonical SMILES,"Mw,g*mol-1","CC50/IC50/EC50, mM","Statistics (95% CI, SEM, SD, RMSE, SE etc.)","Incubation time, h",Cell line,Method,Reference (author+year+journal),doi,Notes
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium bromide,C21H20BrF3N2O2S,2851858-66-5,[Br-].FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.[Br-],501.368,0.04595,0.00127 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium bromide,C21H20BrF3N2O2S,2851858-66-5,[Br-].FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.[Br-],501.368,0.18726,0.00185 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium hexafluorophosphate(V),C21H20F9N2O2PS,2851858-67-6,FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1.F[P-](F)(F)(F)(F)F,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.F[P-](F)(F)(F)(F)F,566.426,0.08356,0.00215 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium hexafluorophosphate(V),C21H20F9N2O2PS,2851858-67-6,FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1.F[P-](F)(F)(F)(F)F,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.F[P-](F)(F)(F)(F)F,566.426,0.17319,0.00179 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium tetrafluoroborate,C21H20BF7N2O2S,,FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1.F[B-](F)(F)F,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.F[B-](F)(F)F,508.268,0.03073,0.00103 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
(E)-3-(3-(3-hydroxy-4-(((4-(trifluoromethyl)phenyl)imino)methyl)phenoxy)propyl)-4-methylthiazol-3-ium tetrafluoroborate,C21H20BF7N2O2S,,FC(F)(F)C1=CC=C(N=CC2=CC=C(OCCC[N+]3=CSC=C3C)C=C2O)C=C1.F[B-](F)(F)F,Cc1csc[n+]1CCCOc1ccc(C=Nc2ccc(C(F)(F)F)cc2)c(O)c1.F[B-](F)(F)F,508.268,0.14853,0.00215 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-triene, 2,5-dihydroxybenzoate",C37H59FN9O4P3,,O=C([O-])C1=CC(O)=CC=C1O.FC2=CC=C(C=C2)CN3CCN(C)P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,805.858,0.15445,0.0026 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-triene, 2,5-dihydroxybenzoate",C37H59FN9O4P3,,O=C([O-])C1=CC(O)=CC=C1O.FC2=CC=C(C=C2)CN3CCN(C)P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,805.858,0.09597,0.0027 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-triene, 2,5-dihydroxybenzoate",C37H59FN9O4P3,,O=C([O-])C1=CC(O)=CC=C1O.FC2=CC=C(C=C2)CN3CCN(C)P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,805.858,0.06737,0.0024 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL68"
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C37H59FN9O4P3,2460738-25-2,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,805.858,0.06895,0.0027 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral structure.
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C37H59FN9O4P3,2460738-25-2,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,805.858,0.04336,0.0023 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral structure.
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C37H59FN9O4P3,2460738-25-2,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,805.858,0.03238,0.0025 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL69. CAS for neutral structure."
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C33H51FN9O4P3,2460731-30-8,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,749.75,0.14146,0.0029 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral structure.
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C33H51FN9O4P3,2460731-30-8,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,749.75,0.10817,0.0033 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral structure.
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C33H51FN9O4P3,2460731-30-8,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,749.75,0.07435,0.0039 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL62. CAS for neutral structure."
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C33H51FN9O4P3,,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,749.75,0.07905,0.0027 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C33H51FN9O4P3,,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,749.75,0.06891,0.0031 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,
"1-(4-fluorobenzyl)-4-methyl-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C33H51FN9O4P3,,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,749.75,0.03482,0.0026 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL63"
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-88-6,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.16463,0.0026 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-88-6,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.1575,0.0031 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-88-6,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.11148,0.003 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL70. CAS for neutral compound"
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460730-43-0,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.09984,0.0028 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460730-43-0,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.04898,0.0025 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(piperidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5,7,9-trien-6-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460730-43-0,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.03787,0.002 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL71. CAS for neutral compound"
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460731-10-4,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1cc(O)ccc1O,763.777,0.08416,0.0029 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460731-10-4,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1cc(O)ccc1O,763.777,0.06646,0.003 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460731-10-4,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1cc(O)ccc1O,763.777,0.04318,0.0026 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL64. CAS for neutral compound"
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460739-07-3,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1c(O)cccc1O,763.777,0.06953,0.003 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460739-07-3,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1c(O)cccc1O,763.777,0.04397,0.0027 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"1-ethyl-4-(4-fluorobenzyl)-7,7,9,9-tetra(pyrrolidin-1-yl)-1,4,6,8,10-pentaaza-5l5,7l5,9l5-triphosphaspiro[4.5]deca-5(10),6,8-trien-6-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460739-07-3,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCN(P34=NP(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=[NH+]4)CC)C=C2,CCN1CCN(Cc2ccc(F)cc2)P12=NP(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=[NH+]2.O=C([O-])c1c(O)cccc1O,763.777,0.024055,0.0025 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL65. CAS for neutral compound"
3-(4-(tert-butyl)benzyl)-4-methylthiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C17H20F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C(C)(C)C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1csc[n+]1Cc1ccc(C(C)(C)C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,526.546,0.01522,0.00123 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
3-(4-(tert-butyl)benzyl)-4-methylthiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C17H20F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C(C)(C)C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1csc[n+]1Cc1ccc(C(C)(C)C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,526.546,0.09181,0.00735 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
3-(4-(tert-butyl)benzyl)-4-methylthiazol-3-ium tetrafluoroborate,C15H20BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C(C)(C)C)C=C2,Cc1csc[n+]1Cc1ccc(C(C)(C)C)cc1.F[B-](F)(F)F,333.203,0.05107,0.00233 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
3-(4-(tert-butyl)benzyl)-4-methylthiazol-3-ium tetrafluoroborate,C15H20BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C(C)(C)C)C=C2,Cc1csc[n+]1Cc1ccc(C(C)(C)C)cc1.F[B-](F)(F)F,333.203,0.19126,0.00985 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
3-(4-isopropylbenzyl)-4-methylthiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C16H18F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C(C)C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1csc[n+]1Cc1ccc(C(C)C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,512.519,0.00737,0.00111 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
3-(4-isopropylbenzyl)-4-methylthiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C16H18F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C(C)C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1csc[n+]1Cc1ccc(C(C)C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,512.519,0.07542,0.00809 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
3-(4-isopropylbenzyl)-4-methylthiazol-3-ium tetrafluoroborate,C14H18BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C(C)C)C=C2,Cc1csc[n+]1Cc1ccc(C(C)C)cc1.F[B-](F)(F)F,319.176,0.03573,0.00103 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
3-(4-isopropylbenzyl)-4-methylthiazol-3-ium tetrafluoroborate,C14H18BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C(C)C)C=C2,Cc1csc[n+]1Cc1ccc(C(C)C)cc1.F[B-](F)(F)F,319.176,0.15224,0.00915 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
3-dodecyl-4-methylthiazol-3-ium bromide,C16H30BrNS,74861-31-7,[Br-].S1C=C([N+](=C1)CCCCCCCCCCCC)C,CCCCCCCCCCCC[n+]1cscc1C.[Br-],348.394,0.01846,0.00186 (ND),48,HT29,SRB,"Vraneš, 2019, J. Chem. Thermodyn.",10.1016/j.jct.2018.12.021,
3-dodecyl-4-methylthiazol-3-ium bromide,C16H30BrNS,74861-31-7,[Br-].S1C=C([N+](=C1)CCCCCCCCCCCC)C,CCCCCCCCCCCC[n+]1cscc1C.[Br-],348.394,0.03196,0.00107 (ND),48,MRC-5,SRB,"Vraneš, 2019, J. Chem. Thermodyn.",10.1016/j.jct.2018.12.021,
3-dodecylthiazol-3-ium bromide,C15H28BrNS,51803-85-1,[Br-].S1C=C[N+](=C1)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccsc1.[Br-],334.367,<0.0067,,48,HT29,SRB,"Vraneš, 2019, J. Chem. Thermodyn.",10.1016/j.jct.2018.12.021,
3-dodecylthiazol-3-ium bromide,C15H28BrNS,51803-85-1,[Br-].S1C=C[N+](=C1)CCCCCCCCCCCC,CCCCCCCCCCCC[n+]1ccsc1.[Br-],334.367,0.01764,0.00069 (ND),48,MRC-5,SRB,"Vraneš, 2019, J. Chem. Thermodyn.",10.1016/j.jct.2018.12.021,
4-methyl-3-(4-methylbenzyl)thiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C14H14F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1ccc(C[n+]2cscc2C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,484.465,0.02131,0.00105 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
4-methyl-3-(4-methylbenzyl)thiazol-3-ium bis((trifluoromethyl)sulfonyl)imide,C14H14F6N2O4S3,,CC1=CSC=[N+]1CC2=CC=C(C)C=C2.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,Cc1ccc(C[n+]2cscc2C)cc1.O=S(=O)([N-]S(=O)(=O)C(F)(F)F)C(F)(F)F,484.465,0.11319,0.00739 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
4-methyl-3-(4-methylbenzyl)thiazol-3-ium tetrafluoroborate,C12H14BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C)C=C2,Cc1ccc(C[n+]2cscc2C)cc1.F[B-](F)(F)F,291.122,0.07795,0.00135 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,
4-methyl-3-(4-methylbenzyl)thiazol-3-ium tetrafluoroborate,C12H14BF4NS,,F[B-](F)(F)F.CC1=CSC=[N+]1CC2=CC=C(C)C=C2,Cc1ccc(C[n+]2cscc2C)cc1.F[B-](F)(F)F,291.122,0.17752,0.00879 (SD),24,HDFa,MTT,"Alfaifi, 2022, RSC Adv.",10.1039/d1ra07128a,Human skin fibroblasts
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-37-5,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.15884,0.003 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-37-5,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.10438,0.003 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C38H61FN9O4P3,2460731-37-5,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1cc(O)ccc1O,819.885,0.1041,0.003 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL72. CAS for neutral compound"
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460733-03-1,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.05303,0.0022 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460733-03-1,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.03861,0.002 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(piperidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C38H61FN9O4P3,2460733-03-1,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCCC5)(N6CCCCC6)=NP(N7CCCCC7)(N8CCCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCCC1)(N1CCCCC1)=NP(N1CCCCC1)(N1CCCCC1)=N2.O=C([O-])c1c(O)cccc1O,819.885,0.02304,0.0021 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL73. CAS for neutral compound"
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460730-32-7,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,763.777,0.09049,0.0022 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460730-32-7,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,763.777,0.06657,0.0028 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,5-dihydroxybenzoate",C34H53FN9O4P3,2460730-32-7,O=C(C1=CC(O)=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1cc(O)ccc1O,763.777,0.08418,0.0028 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL66. CAS for neutral compound"
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460732-60-7,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,763.777,0.07684,0.0025 (SEM),overnight,A549,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460732-60-7,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,763.777,0.04272,0.0022 (SEM),overnight,Hep3B,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,CAS for neutral compound
"7-(4-fluorobenzyl)-11-methyl-2,2,4,4-tetra(pyrrolidin-1-yl)-1,3,5,7,11-pentaaza-2l5,4l5,6l5-triphosphaspiro[5.5]undeca-1(6),2,4-trien-1-ium 2,6-dihydroxybenzoate",C34H53FN9O4P3,2460732-60-7,O=C(C1=C(O)C=CC=C1O)[O-].FC2=CC=C(CN3CCCN(P34=[NH+]P(N5CCCC5)(N6CCCC6)=NP(N7CCCC7)(N8CCCC8)=N4)C)C=C2,CN1CCCN(Cc2ccc(F)cc2)P12=[NH+]P(N1CCCC1)(N1CCCC1)=NP(N1CCCC1)(N1CCCC1)=N2.O=C([O-])c1c(O)cccc1O,763.777,0.03849,0.0026 (SEM),overnight,FL,MTT,"Okumuş, 2017, ChemistrySelect",10.1002/slct.201700497,"FL cells, ATCC CCL67. CAS for neutral compound"
bromide (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38Br2F6N4O4PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.[Br-].[Br-],Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.[Br-].[Br-],1107.14,0.01143,0.00107 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
bromide (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38Br2F6N4O4PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.[Br-].[Br-],Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.[Br-].[Br-],1107.14,0.08957,0.00235 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
hexafluorophosphate(V) (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38F18N4O4P2PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,1237.256,0.02301,0.00125 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
hexafluorophosphate(V) (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38F18N4O4P2PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.F[P-](F)(F)(F)(F)F.F[P-](F)(F)(F)(F)F,1237.256,0.11289,0.00139 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
tetrafluoroborate (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38B2F14N4O4PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.F[B-](F)(F)F.F[B-](F)(F)F,Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.F[B-](F)(F)F.F[B-](F)(F)F,1120.94,0.00671,0.00109 (SD),24,SK-OV-3,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,
tetrafluoroborate (trans-di((E)-5-(3-(4-methylthiazol-3-ium-3-yl)propoxy)-2-(((4-(trifluoromethyl)phenyl)imino)methyl)phenolate))palladium(II),C42H38B2F14N4O4PdS2,,CC1=CSC=[N+]1CCCOC2=CC(O[Pd-2]3([N+](C4=CC=C(C(F)(F)F)C=C4)=CC(C=CC(OCCC[N+]5=CSC=C5C)=C6)=C6O3)[N+](C7=CC=C(C(F)(F)F)C=C7)=C8)=C8C=C2.F[B-](F)(F)F.F[B-](F)(F)F,Cc1csc[n+]1CCCOc1ccc2c(c1)O[Pd-2]1(Oc3cc(OCCC[n+]4cscc4C)ccc3C=[N+]1c1ccc(C(F)(F)F)cc1)[N+](c1ccc(C(F)(F)F)cc1)=C2.F[B-](F)(F)F.F[B-](F)(F)F,1120.94,0.07163,0.00109 (SD),24,HDFa,MTT,"Alfaifi, 2022, J. Mol. Struct.",10.1016/j.molstruc.2021.131594,Human skin fibroblasts
